Poseida Therapeutics, Inc.

CIK 1661460 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Poseida Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2025SCHEDULE 13G/A0000905148-25-001763
Feb 14, 2025SCHEDULE 13G0000905148-25-000686
Feb 7, 2025SCHEDULE 13G/A0000315066-25-000429
Feb 7, 2025SCHEDULE 13G/A0000315066-25-000404
Jan 21, 202515-12G0001193125-25-008945
Jan 15, 2025SCHEDULE 13G/A0001104659-25-003781
Jan 13, 2025SCHEDULE 13D/A0000902664-25-000190
Jan 10, 2025EFFECT9999999995-25-000073
Jan 10, 202540001104659-25-002540
Jan 10, 2025EFFECT9999999995-25-000071
Jan 8, 202540001415889-25-001081
Jan 8, 202540001415889-25-001086
Jan 8, 2025S-8 POS0001193125-25-003524
Jan 8, 2025SC 14D9/A0001193125-25-003241
Jan 8, 202540001415889-25-001085
Jan 8, 202540001415889-25-001084
Jan 8, 202540001415889-25-001089
Jan 8, 2025POS AM0001193125-25-003484
Jan 8, 202540001415889-25-001080
Jan 8, 20258-K0001193125-25-003248
Jan 8, 2025S-8 POS0001193125-25-003522
Jan 8, 202540001415889-25-001087
Jan 8, 202540001415889-25-001083
Jan 8, 2025SC TO-T/A0001193125-25-003231
Jan 8, 202540001415889-25-001088